(Image Credits: Pixabay) Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective and disease-modifying therapies (DMTs). With current ...
The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.
According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...
Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination ...
The first is Nuplazid, which was approved in 2016 and remains the only approved treatment for hallucinations and delusions ...
It had an excellent phase 1b dataset with a very strong treatment effect on the primary endpoint ... portfolio with leading ...
Veterans are entitled to healthcare if they develop conditions related to their service. But too many of them are dying without being helped.
An electronic nose created by scientists in Tartu may be able to diagnose serious neurological diseases such as Parkinson's ...
Austin, Nov. 11, 2024 (GLOBE NEWSWIRE) --“According to S&S Insider, The Neuroscience Market Size was valued at USD 35.3 ...
The Parkinson’s disease (PD) therapeutic landscape is heavily genericized ... analytics company GlobalData in an overview of ...
On Monday, AbbVie Inc (NYSE:ABBV) stock plunged after two trials investigating emraclidine as a once-daily, oral monotherapy ...
Guests at the AV Awards have raised more than £30,000 for the event’s charity partner, Parkinson’s UK. The AV Awards chose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback